Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.
about
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteriaCode blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavityAntimicrobial resistance in Acinetobacter baumannii: From bench to bedsideThe Mode of Inhibitor Binding to Peptidyl-tRNA Hydrolase: Binding Studies and Structure Determination of Unbound and Bound Peptidyl-tRNA Hydrolase from Acinetobacter baumanniiMultidrug-resistant Acinetobacter baumanniiIsolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumanniiSpecies-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.Clinical characteristics and therapeutic outcomes of nosocomial super-infection in adult bacterial meningitis.Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital.Tracing the emergence of multidrug-resistant Acinetobacter baumannii in a Taiwanese hospital by evaluating the presence of integron gene intI1Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit.The outcomes of using colistin for treating multidrug resistant Acinetobacter species bloodstream infectionsPotential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii.Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis.Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complexSevere pneumonia in the elderly: a multivariate analysis of risk factors.Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.Antimicrobial susceptibility patterns of the gram-negative bacteria isolated from septicemia in Children's Medical Center, Tehran, Iran.Endophthalmitis caused by Acinetobacter baumannii: report of two casesEndophthalmitis caused by Acinetobacter baumanni: a case series.Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.Pharmacodynamics modeling to optimize dosage regimens of sulbactam.Acinetobacter baumannii producing OXA-23 detected in the Czech RepublicMetallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan.Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients.Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran.Treatment of Acinetobacter infections.Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia.Challenges and opportunities for whole-genome sequencing-based surveillance of antibiotic resistance.
P2860
Q24794555-B153AD91-C6B3-4233-9197-43555F3567DDQ26996396-79CCB211-14FB-45C2-8959-0CEA31E98DDDQ27024893-3EE4B721-06F0-4A9D-B693-EBA43E36325AQ27679042-3D210DCD-7492-4BE6-88CA-5BAA4A4E3CEDQ28306885-34A301CA-A9E4-4C5B-9CDB-564E0500D084Q28484243-5AB4CA35-DFDA-4F36-B3ED-E11BFF7079F2Q31158215-50F4956B-88C6-42AD-B8EB-DA87C866A752Q33549724-9699FBC2-970F-493B-8CB7-BF37ADCBD7DFQ33892585-180B1440-A546-4C51-8ADB-15E54ECCD8B9Q33904780-2A516C4E-8924-4AF6-9855-86AC6967864AQ33938143-9D716D46-7088-4980-9FF1-296CB08BE5E9Q34068692-3FE312E2-C602-4DA7-A865-BFF7864F1D89Q34137484-58225EA7-591C-4790-8491-ADEA78F7D9F4Q34612269-72C9B966-5F0A-4F7D-9613-42A217DB88F7Q34634695-75F4D36C-F48E-44FA-B842-1080F9EC405DQ34802631-7A8FE907-B4BD-4075-BE1B-6BDC54A64116Q35271483-C058E639-09E8-4F37-8699-B8BCF90CB176Q35609595-A04A0574-3B4D-4DC9-BEB2-74AA08FC78DEQ35848861-0BDD9FFC-485D-4713-9810-47C3ACE0EFC1Q35995536-F1BA7B46-3940-437C-80B0-206242FD3663Q36096472-0C1178C9-692B-4A71-A3E3-32CE172A43C4Q36182731-050E9196-0921-4B24-BD7D-F96B8E617455Q36298237-00AA5101-05E3-4AE9-918B-977BC9FFF24CQ36452586-D980BA19-9FFD-4C6A-B582-3768548AA6A1Q36478387-353D5B09-24B0-4D67-BDD2-5E23B77B7051Q36497883-65BA1B9A-3A32-457F-9F3E-95A7B3AC7B15Q36685439-8A9DC084-A6FC-49EA-8C10-5EB5D45045B3Q36744790-5666AB4B-24A7-4DA5-8986-41BE87CF0776Q36969820-33AA96A8-2CF0-44EE-A75C-CB7862022E2EQ37025416-42774398-A427-494F-AE68-287AC4F0E2DAQ37071179-66D3CD62-2D93-4805-A164-4A8323B850FDQ37302581-F30AD880-AC88-4041-908D-FB8FBEB20E3FQ37420672-3C282710-ADA3-410F-BF4A-EBEE05C83309Q37504215-5BB002CD-3CF6-41FB-B610-D2370213C760Q37611867-EF49C4C0-36F1-4644-9D53-922ED5DDDA89Q37663353-4B9D6110-4437-4C10-9EA8-E142DA0191B0Q37704397-4A4061AF-5BF0-4C57-894D-5423FF655363Q38473752-47A10BD8-EE13-4F3C-9EE6-78461F33AF75Q38679502-BAA56020-3373-4F50-A992-0A594C21F472Q38992444-92CA68A0-984A-489A-AEAF-9C70950C5FCF
P2860
Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@ast
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@en
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@nl
type
label
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@ast
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@en
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@nl
prefLabel
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@ast
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@en
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@nl
P2093
P2860
P356
P1476
Pandrug-resistant Acinetobacte ...... a university hospital, Taiwan.
@en
P2093
Cheng-Yi Chen
Chong-Jen Yu
Kwen-Tay Luh
Lee-Jene Teng
Shen-Wu Ho
Wen-Hwei Chen
P2860
P304
P356
10.3201/EID0805.020014
P50
P577
2002-08-01T00:00:00Z